Trial Profile
Prospective open-label study of intra-ocular pressure lowering effects of bimatoprost after switching from latanoprost in open-angle glaucoma patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Glaucoma
- Focus Adverse reactions; Pharmacodynamics
- 05 Dec 2015 New trial record